XML 47 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Consolidated net income (loss) $ (779.4) $ 62.6
Less: net income (loss) from discontinued operations 6.3 (0.6)
Net income (loss) from continuing operations (785.7) 63.2
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:    
Depreciation 131.6 127.0
Amortization 54.8 56.1
Other long-lived asset impairment charges 0.7 1.0
Goodwill impairment charges 847.8  
Other 3.0 (0.8)
Deferred income taxes (70.9) (35.6)
Change in operating assets and liabilities (23.0) (56.9)
Cash provided by operating activities of continuing operations 158.3 154.0
Cash provided by (used in) operating activities of discontinued operations (3.6) 7.5
Net cash provided by operating activities 154.7 161.5
Cash flows from investing activities:    
Capital expenditures (116.5) (139.6)
Acquisitions, net of cash acquired   (6.1)
Proceeds from sale of assets and other 8.0 3.9
Cash used in investing activities of continuing operations (108.5) (141.8)
Cash provided by (used in) investing activities of discontinued operations 46.4 (6.4)
Net cash used in investing activities (62.1) (148.2)
Cash flows from financing activities:    
Borrowings under ABL revolver   148.9
Repayments under ABL revolver   (148.9)
Issuance of long-term debt 248.8  
Repayments of long-term debt (196.8) (4.9)
Fees paid related to financing activities (3.5) (0.6)
Deferred acquisition payments (10.0) (10.0)
Dividends paid (34.4) (33.8)
Distribution to noncontrolling interest (8.4) (7.7)
Share-based compensation plan activity (6.4) (4.7)
Net cash used in financing activities (10.7) (61.7)
Effect of exchange rate changes on cash and cash equivalents (8.2) (4.4)
Net change in cash and cash equivalents 73.7 (52.8)
Cash and cash equivalents at beginning of period 166.8 166.5
Cash and cash equivalents at end of period $ 240.5 $ 113.7